{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T04:40:17Z","timestamp":1792644017378,"version":"4.5.0"},"reference-count":129,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.ejmech.2026.119347","type":"journal-article","created":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T15:38:57Z","timestamp":1790350737000},"page":"119347","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Non-\u03b2-lactam inhibitors targeting KPC-2 \u03b2-lactamase: Structural insights and rational design strategies to combat antimicrobial drug resistance"],"prefix":"10.1016","volume":"320","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-7771-3599","authenticated-orcid":false,"given":"Mustafa Hassan","family":"Ibrahim Kashkosh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7298-3355","authenticated-orcid":false,"given":"Saroj","family":"Verma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2026.119347_bib1","series-title":"Tackling Drug-Resistant Infections Globally: Final Report and Recommendations","author":"O'Neill","year":"2016"},{"key":"10.1016\/j.ejmech.2026.119347_bib2","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1016\/S0140-6736(24)01867-1","article-title":"Global burden of bacterial antimicrobial resistance 1990\u20132021: a systematic analysis with forecasts to 2050","volume":"404","author":"Naghavi","year":"2024","journal-title":"Lancet"},{"key":"10.1016\/j.ejmech.2026.119347_bib3","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1042\/bj2760269","article-title":"A standard numbering scheme for the class A \u03b2-lactamases","volume":"276","author":"Ambler","year":"1991","journal-title":"Biochem. J."},{"key":"10.1016\/j.ejmech.2026.119347_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2023.105493","article-title":"Klebsiella pneumoniae carbapenemase variant 44 acquires ceftazidime-avibactam resistance by altering the conformation of active-site loops","volume":"300","author":"Sun","year":"2024","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejmech.2026.119347_bib13","doi-asserted-by":"crossref","first-page":"4943","DOI":"10.1128\/AAC.00296-11","article-title":"Carbapenems: past, present, and future","volume":"55","author":"Papp-Wallace","year":"2011","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2026.119347_bib5","doi-asserted-by":"crossref","first-page":"2286","DOI":"10.1128\/AAC.00107-16","article-title":"Global dissemination of blaKPC into bacterial species beyond Klebsiella pneumoniae and in vitro susceptibility to ceftazidime-avibactam and aztreonam-avibactam, antimicrob","volume":"60","author":"Kazmierczak","year":"2016","journal-title":"Agents Chemother"},{"key":"10.1016\/j.ejmech.2026.119347_bib6","doi-asserted-by":"crossref","first-page":"1812","DOI":"10.1093\/jac\/dky105","article-title":"KPC-2 carbapenemase-producing Pseudomonas aeruginosa reaching Germany","volume":"73","author":"Hagemann","year":"2018","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.ejmech.2026.119347_bib7","series-title":"Pathogens Prioritization: a Scientific Framework for Epidemic and Pandemic Research Preparedness","year":"2024"},{"key":"10.1016\/j.ejmech.2026.119347_bib8","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1128\/CMR.00037-09","article-title":"Three decades of \u03b2-lactamase inhibitors","volume":"23","author":"Drawz","year":"2010","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.ejmech.2026.119347_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2022.114677","article-title":"Recent advances in \u03b2-lactamase inhibitor chemotypes and inhibition modes","volume":"242","author":"Li","year":"2022","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119347_bib10","doi-asserted-by":"crossref","first-page":"206","DOI":"10.3390\/ph18020206","article-title":"Breakthrough advances in beta-lactamase inhibitors: new synthesized compounds and mechanisms of action against drug-resistant bacteria","volume":"18","author":"Huang","year":"2025","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.ejmech.2026.119347_bib11","doi-asserted-by":"crossref","DOI":"10.1155\/ijm\/4479031","article-title":"A review of \u03b2-Lactamase inhibitors in clinical use and development: mechanisms, spectrum, and therapeutic applications","volume":"2026","author":"Gourabi","year":"2026","journal-title":"Int. J. Microbiol."},{"key":"10.1016\/j.ejmech.2026.119347_bib12","article-title":"Relative inhibitory activities of newly developed diazabicyclooctanes, boronic acid derivatives, and penicillin-based sulfone \u03b2-lactamase inhibitors against broad-spectrum AmpC \u03b2-lactamases","volume":"68","author":"Le Terrier","year":"2024","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2026.119347_bib14","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S0924-8579(98)00094-6","article-title":"Carbapenems in clinical practice: a guide to their use in serious infection","volume":"11","author":"Bradley","year":"1999","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.ejmech.2026.119347_bib15","doi-asserted-by":"crossref","first-page":"668","DOI":"10.7164\/antibiotics.29.668","article-title":"Naturally-occurring \u03b2-lactamase inhibitors with antibacterial activity","volume":"29","author":"Brown","year":"1976","journal-title":"J. Antibiot."},{"key":"10.1016\/j.ejmech.2026.119347_bib16","doi-asserted-by":"crossref","first-page":"637","DOI":"10.7164\/antibiotics.34.637","article-title":"Epithienamycins. II. Isolation and structure assignment","volume":"34","author":"Cassidy","year":"1981","journal-title":"J. Antibiot."},{"key":"10.1016\/j.ejmech.2026.119347_bib17","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1128\/CMR.00001-07","article-title":"Carbapenemases: the versatile \u03b2-lactamases","volume":"20","author":"Queenan","year":"2007","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.ejmech.2026.119347_bib18","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1038\/s41579-019-0159-8","article-title":"Interplay between \u03b2-lactamases and new \u03b2-lactamase inhibitors","volume":"17","author":"Bush","year":"2019","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.ejmech.2026.119347_bib19","first-page":"401","article-title":"Three decades of the class A \u03b2-lactamase acyl-enzyme, curr. Protein pept","volume":"10","author":"Fisher","year":"2009","journal-title":"Sci"},{"key":"10.1016\/j.ejmech.2026.119347_bib20","doi-asserted-by":"crossref","first-page":"3525","DOI":"10.1021\/acs.jmedchem.7b00158","article-title":"Molecular basis of substrate recognition and product release by the klebsiella pneumoniae carbapenemase (KPC-2)","volume":"60","author":"Pemberton","year":"2017","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119347_bib21","doi-asserted-by":"crossref","first-page":"3186","DOI":"10.1016\/S0021-9258(18)49972-3","article-title":"Site-directed mutants, at position 166, of RTEM-1 \u03b2-lactamase that form a stable acyl-enzyme intermediate with penicillin","volume":"266","author":"Adachi","year":"1991","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejmech.2026.119347_bib22","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1002\/cmdc.201700788","article-title":"Phenylboronic acid derivatives as validated leads active in clinical strains overexpressing KPC-2: a step against bacterial resistance","volume":"13","author":"Celenza","year":"2018","journal-title":"ChemMedChem"},{"key":"10.1016\/j.ejmech.2026.119347_bib23","article-title":"The hydrolytic water molecule of class A \u03b2-lactamase relies on the acyl-enzyme intermediate ES* for proper coordination and catalysis","volume":"10","author":"He","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejmech.2026.119347_bib24","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1128\/CMR.05035-11","article-title":"Carbapenemases in Klebsiella pneumoniae and other enterobacteriaceae: an evolving crisis of global dimensions","volume":"25","author":"Tzouvelekis","year":"2012","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.ejmech.2026.119347_bib25","doi-asserted-by":"crossref","first-page":"26714","DOI":"10.1074\/jbc.273.41.26714","article-title":"X-ray analysis of the NMC-A \u03b2-lactamase at 1.64-\u00c5 resolution, a class A carbapenemase with broad substrate specificity","volume":"273","author":"Swar\u00e9n","year":"1998","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejmech.2026.119347_bib26","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1107\/S0907444901019606","article-title":"Structure of the imipenem-hydrolyzing class A \u03b2-lactamase SME-1 from Serratia marcescens","volume":"58","author":"Sougakoff","year":"2002","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"10.1016\/j.ejmech.2026.119347_bib27","doi-asserted-by":"crossref","first-page":"18275","DOI":"10.1021\/ja304460j","article-title":"The basis for carbapenem hydrolysis by class A \u03b2-lactamases: a combined investigation using crystallography and simulations","volume":"134","author":"Fonseca","year":"2012","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.ejmech.2026.119347_bib28","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1021\/acsinfecdis.2c00152","article-title":"QM\/MM simulations reveal the determinants of carbapenemase activity in class A \u03b2-lactamases","volume":"8","author":"Chudyk","year":"2022","journal-title":"ACS Infect. Dis."},{"key":"10.1016\/j.ejmech.2026.119347_bib29","doi-asserted-by":"crossref","first-page":"4501","DOI":"10.1021\/cr000033x","article-title":"Serine protease mechanism and specificity","volume":"102","author":"Hedstrom","year":"2002","journal-title":"Chem. Rev."},{"key":"10.1016\/j.ejmech.2026.119347_bib30","series-title":"Enzyme-Mediated Resistance to Antibiotics: Mechanisms, Dissemination, and Prospects for Inhibition","first-page":"67","article-title":"Kinetics of \u03b2-lactamases and penicillin-binding proteins","author":"Galleni","year":"2007"},{"key":"10.1016\/j.ejmech.2026.119347_bib31","doi-asserted-by":"crossref","first-page":"16","DOI":"10.3389\/fmolb.2018.00016","article-title":"Structural and mechanistic basis for extended-spectrum drug-resistance mutations in altering the specificity of TEM, CTX-M, and KPC \u03b2-lactamases","volume":"5","author":"Palzkill","year":"2018","journal-title":"Front. Mol. Biosci."},{"key":"10.1016\/j.ejmech.2026.119347_bib32","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/j.mib.2011.07.026","article-title":"Diazabicyclooctanes (DBOs): a potent new class of non-\u03b2-lactam \u03b2-lactamase inhibitors","volume":"14","author":"Coleman","year":"2011","journal-title":"Curr. Opin. Microbiol."},{"key":"10.1016\/j.ejmech.2026.119347_bib33","doi-asserted-by":"crossref","first-page":"12511","DOI":"10.1021\/acs.jmedchem.0c00579","article-title":"Discovery of an orally available diazabicyclooctane inhibitor (ETX0282) of class A, C, and D serine \u03b2-Lactamases","volume":"63","author":"Durand-R\u00e9ville","year":"2020","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119347_bib34","doi-asserted-by":"crossref","first-page":"4067","DOI":"10.1021\/acs.jmedchem.8b00091","article-title":"Strategic approaches to overcome resistance against Gram-negative pathogens using \u03b2-lactamase inhibitors and \u03b2-lactam enhancers: activity of three novel diazabicyclooctanes WCK 5153, zidebactam (WCK 5107), and WCK 4234","volume":"61","author":"Papp-Wallace","year":"2018","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119347_bib35","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00432-19","article-title":"Nacubactam enhances meropenem activity against carbapenem-resistant Klebsiella pneumoniae producing KPC","volume":"63","author":"Barnes","year":"2019","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2026.119347_bib36","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1093\/jac\/dkw593","article-title":"In vitro activity of cefepime\/zidebactam (WCK 5222) against Gram-negative bacteria","volume":"72","author":"Livermore","year":"2017","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.ejmech.2026.119347_bib37","doi-asserted-by":"crossref","DOI":"10.1038\/nmicrobiol.2017.104","article-title":"ETX2514 is a broad-spectrum \u03b2-lactamase inhibitor for the treatment of drug-resistant Gram-negative bacteria including Acinetobacter baumannii","volume":"2","author":"Durand-R\u00e9ville","year":"2017","journal-title":"Nat. Microbiol."},{"key":"10.1016\/j.ejmech.2026.119347_bib38","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.02073-20","article-title":"Structural investigations of the inhibition of Escherichia coli AmpC \u03b2-lactamase by diazabicyclooctanes","volume":"65","author":"Lang","year":"2021","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2026.119347_bib39","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01757-20","article-title":"Structural and biochemical characterization of the novel CTX-M-151 extended-spectrum \u03b2-Lactamase and its inhibition by avibactam","volume":"65","author":"Ghiglione","year":"2021","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2026.119347_bib40","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00564-19","article-title":"Molecular basis of class A \u03b2-Lactamase inhibition by relebactam","volume":"63","author":"Tooke","year":"2019","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2026.119347_bib41","doi-asserted-by":"crossref","first-page":"5441","DOI":"10.1039\/D5MD00512D","article-title":"Electrostatic interactions influence diazabicyclooctane inhibitor potency against OXA-48-like \u03b2-lactamases","volume":"16","author":"Hoff","year":"2025","journal-title":"RSC Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119347_bib42","doi-asserted-by":"crossref","first-page":"5704","DOI":"10.1128\/AAC.03057-14","article-title":"Avibactam and class C \u03b2-Lactamases: mechanism of inhibition, conservation of the binding pocket, and implications for resistance","volume":"58","author":"Lahiri","year":"2014","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2026.119347_bib43","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01757-20","article-title":"Structural and biochemical characterization of the novel CTX-M-151 extended-spectrum \u03b2-Lactamase and its inhibition by avibactam","volume":"65","author":"Ghiglione","year":"2021","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2026.119347_bib44","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1128\/AAC.02073-20","article-title":"Structural investigations of the inhibition of Escherichia coli AmpC \u03b2-lactamase by diazabicyclooctanes","volume":"65","author":"Lang","year":"2021","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2026.119347_bib45","doi-asserted-by":"crossref","first-page":"5441","DOI":"10.1039\/D5MD00512D","article-title":"Electrostatic interactions influence diazabicyclooctane inhibitor potency against OXA-48-like \u03b2-lactamases","volume":"16","author":"Hoff","year":"2025","journal-title":"RSC Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119347_bib46","doi-asserted-by":"crossref","DOI":"10.1128\/aac.00930-22","article-title":"Boronic acid transition state inhibitors as potent inactivators of KPC and CTX-M \u03b2-lactamases: biochemical and structural analyses","volume":"67","author":"Alsenani","year":"2023","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2026.119347_bib47","doi-asserted-by":"crossref","first-page":"2496","DOI":"10.1128\/AAC.02247-12","article-title":"Structural insight into potent broad-spectrum inhibition with reversible recyclization mechanism: avibactam in complex with CTX-M-15 and Pseudomonas aeruginosa AmpC \u03b2-lactamases","volume":"57","author":"Lahiri","year":"2013","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2026.119347_bib48","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1002\/tcr.201402100","article-title":"Boron-based drug design","volume":"15","author":"Ban","year":"2015","journal-title":"Chem. Rec."},{"key":"10.1016\/j.ejmech.2026.119347_bib49","doi-asserted-by":"crossref","first-page":"653","DOI":"10.4155\/fmc.13.38","article-title":"Boron chemicals in diagnosis and therapeutics","volume":"5","author":"Das","year":"2013","journal-title":"Future Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119347_bib50","doi-asserted-by":"crossref","first-page":"2441","DOI":"10.1021\/acs.chemrev.3c00663","article-title":"The rise of boron-containing compounds: advancements in synthesis, medicinal chemistry, and emerging pharmacology","volume":"124","author":"Grams","year":"2024","journal-title":"Chem. Rev."},{"key":"10.1016\/j.ejmech.2026.119347_bib51","doi-asserted-by":"crossref","first-page":"2332","DOI":"10.1007\/s11172-025-4716-1","article-title":"Boronic acids: broad specificity of inhibition of penicillin-binding proteins and \u03b2-lactamases conferring bacterial antibiotic resistance","volume":"74","author":"Egorov","year":"2025","journal-title":"Russ. Chem. Bull."},{"key":"10.1016\/j.ejmech.2026.119347_bib52","doi-asserted-by":"crossref","first-page":"8270","DOI":"10.2174\/0109298673364996250507091821","article-title":"Trends on potential boron-containing drugs by advancements in ligand-protein crystals complexes","volume":"32","author":"Soriano-Urs\u00faa","year":"2025","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119347_bib53","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1093\/jac\/dkq124","article-title":"Inhibitor-based methods for the detection of KPC carbapenemase-producing enterobacteriaceae in clinical practice by using boronic acid compounds","volume":"65","author":"Pournaras","year":"2010","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.ejmech.2026.119347_bib54","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1042\/bj1690197","article-title":"Reversible inhibitors of penicillinases","volume":"169","author":"Kiener","year":"1978","journal-title":"Biochem. J."},{"key":"10.1016\/j.ejmech.2026.119347_bib55","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1042\/bj2090229","article-title":"The inhibition of class C \u03b2-lactamases by boronic acids","volume":"209","author":"Beesley","year":"1983","journal-title":"Biochem. J."},{"key":"10.1016\/j.ejmech.2026.119347_bib56","doi-asserted-by":"crossref","first-page":"7852","DOI":"10.1021\/jm101015z","article-title":"Design, synthesis, crystal structures, and antimicrobial activity of sulfonamide boronic acids as \u03b2-lactamase inhibitors","volume":"53","author":"Eidam","year":"2010","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119347_bib57","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1128\/CMR.00037-09","article-title":"Three decades of \u03b2-lactamase inhibitors","volume":"23","author":"Drawz","year":"2010","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.ejmech.2026.119347_bib58","doi-asserted-by":"crossref","first-page":"17448","DOI":"10.1073\/pnas.1208337109","article-title":"Fragment-guided design of subnanomolar \u03b2-lactamase inhibitors active in vivo","volume":"109","author":"Eidam","year":"2012","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ejmech.2026.119347_bib59","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01935-19","article-title":"Biochemical activity of vaborbactam","volume":"64","author":"Tsivkovski","year":"2020","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2026.119347_bib60","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2021.697180","article-title":"QPX7728, an ultra-broad-spectrum \u03b2-lactamase inhibitor for intravenous and oral therapy: overview of biochemical and microbiological characteristics","volume":"12","author":"Lomovskaya","year":"2021","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.ejmech.2026.119347_bib61","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01963-19","article-title":"VNRX-5133 (taniborbactam), a broad-spectrum inhibitor of serine- and metallo-\u03b2-lactamases, restores activity of cefepime in Enterobacterales and Pseudomonas aeruginosa","volume":"64","author":"Hamrick","year":"2020","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2026.119347_bib62","doi-asserted-by":"crossref","first-page":"3682","DOI":"10.1021\/acs.jmedchem.5b00127","article-title":"Discovery of a cyclic boronic acid \u03b2-lactamase inhibitor (RPX7009) with utility vs class A serine carbapenemases","volume":"58","author":"Hecker","year":"2015","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119347_bib63","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1128\/AAC.02641-15","article-title":"Boronic acid transition state inhibitors active against KPC and other class A \u03b2-lactamases: Structure\u2013activity relationships as a guide to inhibitor design","volume":"60","author":"Rojas","year":"2016","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2026.119347_bib64","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1002\/cmdc.202000126","article-title":"\u03b1-Triazolylboronic acids: a promising scaffold for effective inhibitors of KPCs","volume":"15","author":"Introvigne","year":"2020","journal-title":"ChemMedChem"},{"key":"10.1016\/j.ejmech.2026.119347_bib65","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2022.114571","article-title":"Triazole-substituted phenylboronic acids as tunable lead inhibitors of KPC-2 antibiotic resistance","volume":"240","author":"Zhou","year":"2022","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119347_bib66","doi-asserted-by":"crossref","first-page":"13421","DOI":"10.1021\/acs.jmedchem.5c00058","article-title":"Design and SAR analysis of phenylboronic acid-based inhibitors for sensitizing KPC-2-producing Klebsiella pneumoniae to \u03b2-lactam antibiotics","volume":"68","author":"Singh","year":"2025","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119347_bib67","doi-asserted-by":"crossref","first-page":"3648","DOI":"10.1021\/acs.joc.5c02782","article-title":"Phosphonic acid-boronic acid anhydrides demonstrate class A\u2013D \u03b2-lactamase inhibition","volume":"91","author":"Ospanow","year":"2026","journal-title":"J. Org. Chem."},{"key":"10.1016\/j.ejmech.2026.119347_bib68","doi-asserted-by":"crossref","first-page":"7362","DOI":"10.3390\/molecules28217362","article-title":"Aromatic diboronic acids as effective KPC\/AmpC inhibitors","volume":"28","author":"Krajewska","year":"2023","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2026.119347_bib69","doi-asserted-by":"crossref","DOI":"10.1002\/cmdc.202400901","article-title":"2-Carboxyquinoline boronic acids as highly potent KPC inhibitors","volume":"20","author":"Ma","year":"2025","journal-title":"ChemMedChem"},{"key":"10.1016\/j.ejmech.2026.119347_bib70","article-title":"Bifunctional inhibitors of \u03b2-lactamases and ferroptosis: design, synthesis and anti-gram-negative bacterial infection evaluation","author":"Liu","year":"2026","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119347_bib71","series-title":"Nanostructured Biomaterials, Materials Horizons: from Nature to Nanomaterials","first-page":"307","article-title":"An overview on biological evaluation of tetrazole derivatives","author":"Kabi","year":"2022"},{"key":"10.1016\/j.ejmech.2026.119347_bib72","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.02563-17","article-title":"Antibacterial spectrum of a tetrazole-based reversible inhibitor of serine \u03b2-lactamases","volume":"62","author":"Pemberton","year":"2018","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2026.119347_bib73","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0203241","article-title":"In silico identification and experimental validation of hits active against KPC-2 \u03b2-lactamase","volume":"13","author":"Klein","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.ejmech.2026.119347_bib74","doi-asserted-by":"crossref","first-page":"2713","DOI":"10.1128\/AAC.06099-11","article-title":"Crystal structures of KPC-2 \u03b2-lactamase in complex with 3-nitrophenyl boronic acid and the penam sulfone PSR-3-226","volume":"56","author":"Ke","year":"2012","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2026.119347_bib75","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00398-20","article-title":"Structural basis and binding kinetics of vaborbactam in class A \u03b2-lactamase inhibition","volume":"64","author":"Pemberton","year":"2020","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2026.119347_bib82","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1128\/AAC.02643-15","article-title":"Crystal structures of KPC-2 and SHV-1 \u03b2-lactamases in complex with the boronic acid transition state analog S02030","volume":"60","author":"Nguyen","year":"2016","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2026.119347_bib83","doi-asserted-by":"crossref","first-page":"280","DOI":"10.3390\/ijms21010280","article-title":"GTP preference of d-glycero-\u03b1-d-manno-heptose-1-phosphate guanylyltransferase from Yersinia pseudotuberculosis","volume":"21","author":"Kim","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejmech.2026.119347_bib84","doi-asserted-by":"crossref","first-page":"171","DOI":"10.3390\/antibiotics8040171","article-title":"Phenylboronic acids probing molecular recognition against class A and class C \u03b2-lactamases","volume":"8","author":"Linciano","year":"2019","journal-title":"Antibiotics"},{"key":"10.1016\/j.ejmech.2026.119347_bib85","doi-asserted-by":"crossref","first-page":"7491","DOI":"10.1021\/acs.jmedchem.9b01976","article-title":"Discovery of cyclic boronic acid QPX7728, an ultrabroad-spectrum inhibitor of serine and metallo-\u03b2-lactamases","volume":"63","author":"Hecker","year":"2020","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119347_bib86","doi-asserted-by":"crossref","first-page":"4217","DOI":"10.1021\/acs.biochem.5c00336","article-title":"Structural insights into the role of the stereochemistry of the cyclopropyl ring in the inhibitory activity of xeruborbactam against SME-1 class A carbapenemase","volume":"64","author":"Dhankhar","year":"2025","journal-title":"Biochemistry"},{"key":"10.1016\/j.ejmech.2026.119347_bib87","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1039\/D5OB01703C","article-title":"Beyond structure and activity: targeting class A carbapenemases with monocyclic and bicyclic boronic acids to counter antimicrobial resistance","volume":"24","author":"Dhankhar","year":"2026","journal-title":"Org. Biomol. Chem."},{"key":"10.1016\/j.ejmech.2026.119347_bib76","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1039\/D5OB01703C","article-title":"Beyond structure and activity: targeting class A carbapenemases with monocyclic and bicyclic boronic acids to counter antimicrobial resistance","volume":"24","author":"Dhankhar","year":"2026","journal-title":"Org. Biomol. Chem."},{"key":"10.1016\/j.ejmech.2026.119347_bib77","doi-asserted-by":"crossref","first-page":"7491","DOI":"10.1021\/acs.jmedchem.9b01976","article-title":"Discovery of cyclic boronic acid QPX7728, an ultrabroad-spectrum inhibitor of serine and metallo-\u03b2-lactamases","volume":"63","author":"Hecker","year":"2020","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119347_bib78","doi-asserted-by":"crossref","first-page":"4217","DOI":"10.1021\/acs.biochem.5c00336","article-title":"Structural insights into the role of the stereochemistry of the cyclopropyl ring in the inhibitory activity of xeruborbactam against SME-1 class A carbapenemase","volume":"64","author":"Dhankhar","year":"2025","journal-title":"Biochemistry"},{"key":"10.1016\/j.ejmech.2026.119347_bib79","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1021\/acsmedchemlett.8b00607","article-title":"X-ray crystallography deciphers the activity of broad-spectrum boronic acid \u03b2-lactamase inhibitors","volume":"10","author":"Cendron","year":"2019","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2026.119347_bib80","doi-asserted-by":"crossref","first-page":"171","DOI":"10.3390\/antibiotics8040171","article-title":"Phenylboronic acids probing molecular recognition against class A and class C \u03b2-lactamases","volume":"8","author":"Linciano","year":"2019","journal-title":"Antibiotics"},{"key":"10.1016\/j.ejmech.2026.119347_bib81","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.2174\/0929867322666150209151209","article-title":"Target based drug design \u2013 a reality in virtual sphere","volume":"22","author":"Verma","year":"2015","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119347_bib88","doi-asserted-by":"crossref","first-page":"3725","DOI":"10.1128\/AAC.00163-08","article-title":"Genetic and structural insights into the dissemination potential of the extremely broad-spectrum class A \u03b2-lactamase KPC-2 identified in an Escherichia coli strain and an Enterobacter cloacae strain isolated from the same patient in France, antimicrob","volume":"52","author":"Petrella","year":"2008","journal-title":"Agents Chemother"},{"key":"10.1016\/j.ejmech.2026.119347_bib89","doi-asserted-by":"crossref","first-page":"59","DOI":"10.3390\/antibiotics13010059","article-title":"Drug discovery in the field of \u03b2-lactams: an academic perspective","volume":"13","author":"Jacobs","year":"2024","journal-title":"Antibiotics"},{"key":"10.1016\/j.ejmech.2026.119347_bib90","doi-asserted-by":"crossref","first-page":"5732","DOI":"10.1021\/bi700300u","article-title":"Crystal structure of KPC-2: insights into carbapenemase activity in class A \u03b2-lactamases","volume":"46","author":"Ke","year":"2007","journal-title":"Biochemistry"},{"key":"10.1016\/j.ejmech.2026.119347_bib91","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms12406","article-title":"Structural basis of metallo-\u03b2-lactamase, serine-\u03b2-lactamase and penicillin-binding protein inhibition by cyclic boronates","volume":"7","author":"Brem","year":"2016","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ejmech.2026.119347_bib92","doi-asserted-by":"crossref","first-page":"5449","DOI":"10.1021\/jm5006572","article-title":"Targeting class A and C serine \u03b2-lactamases with a broad-spectrum boronic acid derivative","volume":"57","author":"Tondi","year":"2014","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119347_bib93","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1021\/acs.jmedchem.9b01279","article-title":"\u03b2-Lactamase inhibitors to restore the efficacy of antibiotics against superbugs","volume":"63","author":"Gonz\u00e1lez-Bello","year":"2020","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119347_bib94","doi-asserted-by":"crossref","first-page":"4214","DOI":"10.1111\/febs.14643","article-title":"The biological assembly of OXA-48 reveals a dimer interface with high charge complementarity and very high affinity","volume":"285","author":"Lund","year":"2018","journal-title":"FEBS J."},{"key":"10.1016\/j.ejmech.2026.119347_bib95","doi-asserted-by":"crossref","unstructured":"Kim, Y.; Tesar, C.; Jedrzejczak, R.; Joachimiak, A.; Center for structural genomics of infectious diseases (CSGID). Crystal structure of the new Delhi metallo beta lactamase variant 6 klebsiella pneumoniae. protein data Bank, PDB ID: 6MGX. https:\/\/doi.org\/10.2210\/pdb6MGX\/pdb.","DOI":"10.2210\/pdb6mgx\/pdb"},{"key":"10.1016\/j.ejmech.2026.119347_bib96","doi-asserted-by":"crossref","unstructured":"Kim, Y.; Tesar, C.; Jedrzejczak, R.; Babnigg, G.; Joachimiak, A.; Center for structural genomics of infectious diseases (CSGID). Crystal structure of the new Delhi metallo beta lactamase variant 5 from Klebsiella pneumoniae. protein data bank, PDB ID: 6MGY. https:\/\/doi.org\/10.2210\/pdb6MGY\/pdb.","DOI":"10.2210\/pdb6mgy\/pdb"},{"key":"10.1016\/j.ejmech.2026.119347_bib97","doi-asserted-by":"crossref","DOI":"10.1074\/jbc.RA120.015050","article-title":"KPC-2 \u03b2-lactamase enables carbapenem antibiotic resistance through fast deacylation of the covalent intermediate","volume":"296","author":"Mehta","year":"2021","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejmech.2026.119347_bib98","doi-asserted-by":"crossref","DOI":"10.1074\/jbc.RA120.016461","article-title":"Natural variants modify klebsiella pneumoniae carbapenemase (KPC) acyl\u2013enzyme conformational dynamics to extend antibiotic resistance","volume":"296","author":"Tooke","year":"2021","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejmech.2026.119347_bib99","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsb.2022.107922","article-title":"The crystal structure of the H116Q mutant of NDM-1: an enzyme devoid of zinc ions","volume":"214","author":"Kong","year":"2022","journal-title":"J. Struct. Biol."},{"key":"10.1016\/j.ejmech.2026.119347_bib100","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2021.100799","article-title":"Local interactions with the Glu166 base and the conformation of an active site loop play key roles in carbapenem hydrolysis by the KPC-2 \u03b2-lactamase","volume":"296","author":"Furey","year":"2021","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejmech.2026.119347_bib101","doi-asserted-by":"crossref","unstructured":"I.M. Furey, T. Palzkill, L. Hu, B.V.V. Prasad, Crystal structure of KPC-2 S70G\/T215P mutant with hydrolyzed imipenem, protein data bank, PDB ID: 7LR9. https:\/\/doi.org\/10.2210\/pdb7LR9\/pdb.","DOI":"10.2210\/pdb7lr9\/pdb"},{"key":"10.1016\/j.ejmech.2026.119347_bib102","doi-asserted-by":"crossref","DOI":"10.1128\/aac.00350-23","article-title":"Exploring avibactam and relebactam inhibition of Klebsiella pneumoniae carbapenemase D179N variant: role of the \u03a9 loop-held deacylation water, antimicrob","volume":"67","author":"Alsenani","year":"2023","journal-title":"Agents Chemother"},{"key":"10.1016\/j.ejmech.2026.119347_bib103","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1038\/s41586-024-07290-7","article-title":"Structural insights into vesicular monoamine storage and drug interactions","volume":"629","author":"Ye","year":"2024","journal-title":"Nature"},{"key":"10.1016\/j.ejmech.2026.119347_bib104","article-title":"Activities of aztreonam in combination with several novel \u03b2-lactam-\u03b2-lactamase inhibitor combinations against carbapenem-resistant Klebsiella pneumoniae strains coproducing KPC and NDM","volume":"15","author":"Li","year":"2024","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.ejmech.2026.119347_bib105","doi-asserted-by":"crossref","first-page":"3710","DOI":"10.1128\/AAC.04406-14","article-title":"Variants of \u03b2-lactamase KPC-2 that are resistant to inhibition by avibactam","volume":"59","author":"Papp-Wallace","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2026.119347_bib106","doi-asserted-by":"crossref","first-page":"260","DOI":"10.3390\/antibiotics13030260","article-title":"Role of \u03b2-lactamase inhibitors as potentiators in antimicrobial chemotherapy targeting Gram-negative bacteria","volume":"13","author":"Zhang","year":"2024","journal-title":"Antibiotics (Basel)"},{"key":"10.1016\/j.ejmech.2026.119347_bib107","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1038\/s44259-025-00123-1","article-title":"Current economic and regulatory challenges in developing antibiotics for Gram-negative bacteria","volume":"3","author":"Gargate","year":"2025","journal-title":"npj Antimicrob. Resist."},{"key":"10.1016\/j.ejmech.2026.119347_bib108","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.66567","article-title":"Allosteric communication in class A \u03b2-lactamases occurs via cooperative coupling of loop dynamics","volume":"10","author":"Galdadas","year":"2021","journal-title":"eLife"},{"key":"10.1016\/j.ejmech.2026.119347_bib109","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-018-31176-0","article-title":"Defining the architecture of KPC-2 carbapenemase: identifying allosteric networks to fight antibiotic resistance","volume":"8","author":"Galdadas","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejmech.2026.119347_bib110","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.66567","article-title":"Allosteric communication in class A \u03b2-lactamases occurs via cooperative coupling of loop dynamics","volume":"10","author":"Galdadas","year":"2021","journal-title":"eLife"},{"key":"10.1016\/j.ejmech.2026.119347_bib111","doi-asserted-by":"crossref","first-page":"17232","DOI":"10.1039\/D4SC03295K","article-title":"Dynamical responses predict a distal site that modulates activity in an antibiotic resistance enzyme","volume":"15","author":"Beer","year":"2024","journal-title":"Chem. Sci."},{"key":"10.1016\/j.ejmech.2026.119347_bib112","doi-asserted-by":"crossref","first-page":"5571","DOI":"10.1038\/s41467-023-41191-z","article-title":"Exploiting the aggregation propensity of beta-lactamases to design inhibitors that induce enzyme misfolding","volume":"14","author":"Khodaparast","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ejmech.2026.119347_bib113","doi-asserted-by":"crossref","first-page":"44860","DOI":"10.1021\/jacs.5c12405","article-title":"Light-activated metal-dependent protein degradation: a heterobifunctional ruthenium(II) photosensitizer targeting new Delhi metallo-\u03b2-lactamase 1","volume":"147","author":"Stevens-Cullinane","year":"2025","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.ejmech.2026.119347_bib114","doi-asserted-by":"crossref","DOI":"10.1128\/aac.00535-24","article-title":"Multi-year analysis of the global preclinical antibacterial pipeline: trends and gaps","volume":"68","author":"Gigante","year":"2024","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2026.119347_bib115","series-title":"Reports Identify Weakness in Global Pipeline for New Antibiotics, Diagnostics, Center for Infectious Disease Research and Policy (CIDRAP)","author":"Dall","year":"2025"},{"key":"10.1016\/j.ejmech.2026.119347_bib116","doi-asserted-by":"crossref","first-page":"587","DOI":"10.3390\/antibiotics14060587","article-title":"Challenges of carbapenem-resistant enterobacteriaceae in the development of new \u03b2-lactamase inhibitors and antibiotics","volume":"14","author":"Leroux","year":"2025","journal-title":"Antibiotics"},{"issue":"10","key":"10.1016\/j.ejmech.2026.119347_bib117","doi-asserted-by":"crossref","DOI":"10.1016\/j.drudis.2022.06.012","article-title":"Mutation informatics: SARS-coV-2 receptor-binding domain of the spike protein","volume":"27","author":"Verma","year":"2022","journal-title":"Drug Discov. Today"},{"issue":"1","key":"10.1016\/j.ejmech.2026.119347_bib118","doi-asserted-by":"crossref","DOI":"10.1016\/j.drudis.2025.104561","article-title":"Pharmacogenomics and mutation informatics: correlation of NAT2 mutations and isoniazid acetylation rate","volume":"31","author":"Verma","year":"2026","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.ejmech.2026.119347_bib119","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a025239","article-title":"\u03b2-Lactamases: a focus on current challenges","volume":"7","author":"Bonomo","year":"2017","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"10.1016\/j.ejmech.2026.119347_bib120","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1128\/AAC.33.11.1831","article-title":"Outer membrane barrier as a mechanism of antimicrobial resistance","volume":"33","author":"Nikaido","year":"1989","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2026.119347_bib121","doi-asserted-by":"crossref","first-page":"260","DOI":"10.3390\/antibiotics13030260","article-title":"Role of \u03b2-lactamase inhibitors as potentiators in antimicrobial chemotherapy targeting Gram-negative bacteria","volume":"13","author":"Zhang","year":"2024","journal-title":"Antibiotics (Basel)"},{"key":"10.1016\/j.ejmech.2026.119347_bib122","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1038\/s44259-025-00123-1","article-title":"Current economic and regulatory challenges in developing antibiotics for Gram-negative bacteria","volume":"3","author":"Gargate","year":"2025","journal-title":"npj Antimicrob. Resist."},{"key":"10.1016\/j.ejmech.2026.119347_bib123","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01963-19","article-title":"VNRX-5133 (taniborbactam), a broad-spectrum inhibitor of serine- and metallo-\u03b2-lactamases, restores activity of cefepime in Enterobacterales and Pseudomonas aeruginosa","volume":"64","author":"Hamrick","year":"2020","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2026.119347_bib124","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2021.697180","article-title":"QPX7728, an ultra-broad-spectrum \u03b2-lactamase inhibitor for intravenous and oral therapy: overview of biochemical and microbiological characteristics","volume":"12","author":"Lomovskaya","year":"2021","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.ejmech.2026.119347_bib125","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01963-19","article-title":"VNRX-5133 (taniborbactam), a broad-spectrum inhibitor of serine- and metallo-\u03b2-lactamases, restores activity of cefepime in Enterobacterales and Pseudomonas aeruginosa","volume":"64","author":"Hamrick","year":"2020","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2026.119347_bib126","doi-asserted-by":"crossref","DOI":"10.1128\/aac.01511-24","article-title":"Cefepime\u2013taniborbactam and ceftibuten\u2013ledaborbactam maintain activity against KPC variants that lead to ceftazidime\u2013avibactam resistance","volume":"69","author":"Myers","year":"2025","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2026.119347_bib127","doi-asserted-by":"crossref","first-page":"3116","DOI":"10.1093\/jac\/dkae329","article-title":"Cefepime\u2013taniborbactam activity against antimicrobial-resistant clinical isolates of Enterobacterales and Pseudomonas aeruginosa: GEARS global surveillance programme 2018\u201322","volume":"79","author":"Karlowsky","year":"2024","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.ejmech.2026.119347_bib128","doi-asserted-by":"crossref","first-page":"502","DOI":"10.3390\/antibiotics13060502","article-title":"Implications of artificial intelligence in addressing antimicrobial resistance: innovations, global challenges, and healthcare's future","volume":"13","author":"Branda","year":"2024","journal-title":"Antibiotics"},{"key":"10.1016\/j.ejmech.2026.119347_bib129","doi-asserted-by":"crossref","DOI":"10.1111\/1758-2229.70267","article-title":"Antibiotic resistance crisis: from bacterial bioprospecting to artificial intelligence","volume":"17","author":"Cunha-Ferreira","year":"2025","journal-title":"Environ. Microbiol. Rep."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523426007920?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523426007920?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T04:23:35Z","timestamp":1792643015000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523426007920"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":129,"alternative-id":["S0223523426007920"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2026.119347","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Non-\u03b2-lactam inhibitors targeting KPC-2 \u03b2-lactamase: Structural insights and rational design strategies to combat antimicrobial drug resistance","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2026.119347","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"119347"}}